Tuberculosis Research Today is a free monthly online journal that collates and summarizes the latest research about Tuberculosis, including details on symptoms, causes, treatment, pulmonary, mycobacterium. | ||||||||
|
Assessing risk and managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNFalpha treatment.Ormerod LP Chest Clinic, Blackburn Royal Infirmary, Blackburn, Lancashire BB2 3LR, UK. This short paper describes the rationale being applied in the United Kingdom to the problem of treating latent TB infection in persons requiring anti-TNF-alpha treatment. This will largely have to be done by an individual risk/benefit analysis based on the risks of developing disease from national epidemiology compared with the risks of significant hepatotoxicity from treatment of latent infection. Published 13 December 2004 in Cytokine, 28(4): 179-81.
© 2004-2008 Tuberculosis Research Today. All Rights Reserved. |
| ||||||